trending Market Intelligence /marketintelligence/en/news-insights/trending/wfX-XCZFLqwxEiNjTqMicQ2 content esgSubNav
In This List

Orion enters collaboration to develop medicines for oncological diseases

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Orion enters collaboration to develop medicines for oncological diseases

Orion Corp. entered into a strategic collaboration with the Wisconsin Technology Innovation Initiative to develop new medicines for oncological diseases.

The Wisconsin Technology Innovation Initiative is a nonprofit organization formed to support the School of Medicine and Public Health at the University of Wisconsin-Madison.

Under the agreement, target proteins identified and initially validated at the university will be provided to Orion as a first step in establishing a research and development collaboration.

Both parties will cover their own costs throughout the collaboration. All future income related to individual joint projects of the collaboration parties shall be shared between the parties in proportion to their respective share of development investments.